187 related articles for article (PubMed ID: 19172579)
21. Supercritical fluid extraction (SFE) of cranberries does not extract oligomeric proanthocyanidins (PAC) but does alter the chromatography and bioactivity of PAC fractions extracted from SFE residues.
Feliciano RP; Meudt JJ; Shanmuganayagam D; Metzger BT; Krueger CG; Reed JD
J Agric Food Chem; 2014 Aug; 62(31):7730-7. PubMed ID: 25019644
[TBL] [Abstract][Full Text] [Related]
22. Prevention of Urinary Tract Infection with Oximacro, A Cranberry Extract with a High Content of A-Type Proanthocyanidins: A Pre-Clinical Double-Blind Controlled Study.
Occhipinti A; Germano A; Maffei ME
Urol J; 2016 Apr; 13(2):2640-9. PubMed ID: 27085566
[TBL] [Abstract][Full Text] [Related]
23. Cranberry cocktail juice, cranberry concentrates, and proanthocyanidins reduce reovirus infectivity titers in African green monkey kidney epithelial cell cultures.
Lipson SM; Cohen P; Zhou J; Burdowski A; Stotzky G
Mol Nutr Food Res; 2007 Jun; 51(6):752-8. PubMed ID: 17487927
[TBL] [Abstract][Full Text] [Related]
24. Cranberry proanthocyanidins induce apoptosis and inhibit acid-induced proliferation of human esophageal adenocarcinoma cells.
Kresty LA; Howell AB; Baird M
J Agric Food Chem; 2008 Feb; 56(3):676-80. PubMed ID: 18211022
[TBL] [Abstract][Full Text] [Related]
25. Cranberry proanthocyanidins inhibit esophageal adenocarcinoma in vitro and in vivo through pleiotropic cell death induction and PI3K/AKT/mTOR inactivation.
Kresty LA; Weh KM; Zeyzus-Johns B; Perez LN; Howell AB
Oncotarget; 2015 Oct; 6(32):33438-55. PubMed ID: 26378019
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of herpes simplex type 1 and type 2 infections by Oximacro(®), a cranberry extract with a high content of A-type proanthocyanidins (PACs-A).
Terlizzi ME; Occhipinti A; Luganini A; Maffei ME; Gribaudo G
Antiviral Res; 2016 Aug; 132():154-64. PubMed ID: 27321663
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the Degree of Polymerization of the Proanthocyanidins in Cranberry by Molecular Sieving and Characterization of the Low Molecular Weight Fractions by UHPLC-Orbitrap Mass Spectrometry.
Gardana C; Simonetti P
Molecules; 2019 Apr; 24(8):. PubMed ID: 30999600
[TBL] [Abstract][Full Text] [Related]
28. Cranberry A-type proanthocyanidins selectively target acute myeloid leukemia cells.
Bystrom LM; Bezerra DP; Hsu HT; Zong H; Lara-Martínez LA; De Leon JP; Emmanuel M; Méry D; Gardenghi S; Hassane D; Neto CC; Cunningham-Rundles S; Becker MW; Rivella S; Guzman ML
Blood Adv; 2019 Nov; 3(21):3261-3265. PubMed ID: 31698457
[TBL] [Abstract][Full Text] [Related]
29. Proanthocyanidin-rich extracts from cranberry fruit (Vaccinium macrocarpon Ait.) selectively inhibit the growth of human pathogenic fungi Candida spp. and Cryptococcus neoformans.
Patel KD; Scarano FJ; Kondo M; Hurta RA; Neto CC
J Agric Food Chem; 2011 Dec; 59(24):12864-73. PubMed ID: 22066866
[TBL] [Abstract][Full Text] [Related]
30. In vivo inhibition of growth of human tumor lines by flavonoid fractions from cranberry extract.
Ferguson PJ; Kurowska EM; Freeman DJ; Chambers AF; Koropatnick J
Nutr Cancer; 2006; 56(1):86-94. PubMed ID: 17176222
[TBL] [Abstract][Full Text] [Related]
31. Cranberry proanthocyanidins act in synergy with licochalcone A to reduce Porphyromonas gingivalis growth and virulence properties, and to suppress cytokine secretion by macrophages.
Feldman M; Grenier D
J Appl Microbiol; 2012 Aug; 113(2):438-47. PubMed ID: 22563853
[TBL] [Abstract][Full Text] [Related]
32. Cranberry Proanthocyanidins Neutralize the Effects of
Ben Lagha A; Howell A; Grenier D
Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31739483
[No Abstract] [Full Text] [Related]
33. Methods to determine effects of cranberry proanthocyanidins on extraintestinal infections: Relevance for urinary tract health.
Feliciano RP; Krueger CG; Reed JD
Mol Nutr Food Res; 2015 Jul; 59(7):1292-306. PubMed ID: 25917127
[TBL] [Abstract][Full Text] [Related]
34. Fluorescent labeling of cranberry proanthocyanidins with 5-([4,6-dichlorotriazin-2-yl]amino)fluorescein (DTAF).
Feliciano RP; Heintz JA; Krueger CG; Vestling MM; Reed JD
Food Chem; 2015 Jan; 166():337-345. PubMed ID: 25053065
[TBL] [Abstract][Full Text] [Related]
35. A-type cranberry proanthocyanidins inhibit the RANKL-dependent differentiation and function of human osteoclasts.
Tanabe S; Santos J; La VD; Howell AB; Grenier D
Molecules; 2011 Mar; 16(3):2365-74. PubMed ID: 21399573
[TBL] [Abstract][Full Text] [Related]
36. Cranberry-derived proanthocyanidins induce a differential transcriptomic response within Candida albicans urinary biofilms.
Sundararajan A; Rane HS; Ramaraj T; Sena J; Howell AB; Bernardo SM; Schilkey FD; Lee SA
PLoS One; 2018; 13(8):e0201969. PubMed ID: 30089157
[TBL] [Abstract][Full Text] [Related]
37. The specific degree-of-polymerization of A-type proanthocyanidin oligomers impacts Streptococcus mutans glucan-mediated adhesion and transcriptome responses within biofilms.
Feng G; Klein MI; Gregoire S; Singh AP; Vorsa N; Koo H
Biofouling; 2013; 29(6):629-40. PubMed ID: 23697791
[TBL] [Abstract][Full Text] [Related]
38. Lingonberry (Vaccinium vitis-idaea) and European cranberry (Vaccinium microcarpon) proanthocyanidins: isolation, identification, and bioactivities.
Kylli P; Nohynek L; Puupponen-Pimiä R; Westerlund-Wikström B; Leppänen T; Welling J; Moilanen E; Heinonen M
J Agric Food Chem; 2011 Apr; 59(7):3373-84. PubMed ID: 21370878
[TBL] [Abstract][Full Text] [Related]
39. Effect of phytochemical concentrations on biological activities of cranberry extracts.
Menghini L; Leporini L; Scanu N; Pintore G; La Rovere R; Di Filippo ES; Pietrangelo T; Fulle S
J Biol Regul Homeost Agents; 2011; 25(1):27-35. PubMed ID: 21382271
[TBL] [Abstract][Full Text] [Related]
40. A-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity.
Howell AB; Reed JD; Krueger CG; Winterbottom R; Cunningham DG; Leahy M
Phytochemistry; 2005 Sep; 66(18):2281-91. PubMed ID: 16055161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
